Health Professionals

Research helps predict which melanoma patients are most likely to respond to immunotherapy

An international team of UK and US scientists has discovered that the activity of macrophages – a type of white blood cell that engulf pathogens and cancer cells – can be used to predict whether or not a melanoma patient will respond to immunotherapy. Their findings, published in a landmark paper in JCO Oncology Advances, will help clinicians select treatments that are most likely to be effective for their patients.

Read More
MRV News
Melanoma News
Archive
Menu